LIDDS fundamentals
Key facts
Market capitalization—
Founded—
CEO—
Website—
About
LIDDS AB is a drug delivery company based on the proprietary technology NanoZolid, which formulate drugs for local and intratumoral administration. The company was founded on November 4, 1999 and is headquartered in Uppsala, Sweden.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Dividends
Dividend yield, history and sustainability
No dividends
LIDDS has never paid dividends and has no current plans to do so.
Financial health
Financial position and solvency of the company